schizophrenia
Conditions
Sponsors
Sumitomo Dainippon Pharma Co., Ltd.
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion Criteria: (1) Subjects who voluntarily provide written consent to participate in the study. If the subject is considered a minor at the time of collection of the informed consent, written consent will be obtained from a legally acceptable representative (guardian) in addition to that obtained from the subject. (2) Subject who has schizophrenia diagnosed by DSM-5, diagnostic criteria, and in the opinion of the Investigator has been clinically stable. (3) Subject who has CGI-S score>=3 at baseline.
Exclusion criteria
Exclusion criteria: Exclusion Criteria (1)Subjects who has DSM-5 diagnosis consistent with a DSM-5 diagnosis other than schizophrenia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| other The conseqtive days of wearing the devices and the rate of wearing the devices for each devices | — |
Secondary
| Measure | Time frame |
|---|---|
| other Change of the number of steps Sleep activity Questionnaire to patients CGI-S BPRS | — |
Countries
Japan
Outcome results
None listed